Wegovy, Metformin, Tirzepatide: the catch.
Downloadable Weight-Loss Treatment
‘The No Diet, Diet.’
Wegovy, Metformin, Tirzepatide: the catch.
Wegovy, Metformin, Tirzepatide: the catch. In the ever-evolving world of medical science, discoveries often transcend their original purposes to address pressing health concerns. Metformin, initially designed as a diabetes treatment, and Tirzepatide, an FDA approved injectable medication for regulating blood sugar, are prime examples of this phenomenon. Beyond their roles in diabetes management, these drugs are now making waves as game-changers in the realm of weight loss.
Metformin, a widely prescribed medication for managing blood sugar levels in individuals with type 2 diabetes, has long been recognised for its potential in aiding weight loss. Although not initially developed as a weight-loss drug, it has garnered attention for its unexpected benefits in this arena.
Wegovy, Metformin and Tirzepatide: the catch.
Metformin’s Mechanism: Metformin primarily works by reducing the liver’s production of glucose and improving insulin sensitivity. These effects help stabilise blood sugar levels, but they also have implications for weight management. While the weight loss achieved with Metformin may be modest, typically around 5%, it offers hope for those struggling to shed excess pounds. Some individuals taking Metformin have reported positive outcomes, especially when combined with lifestyle modifications.
2. Wegovy: FDA Approved
In contrast to Metformin’s accidental weight loss benefits, Wegovy (Semaglutide) represents a purpose-built solution for obesity management. Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist, was approved by the U.S. Food and Drug Administration (FDA) in 2021 as a breakthrough injectable medication for weight loss. Wegovy, Metformin Tirzepatide the catch.
How Wegovy Works: The primary mechanism of action involves suppressing appetite and increasing feelings of fullness. By targeting the brain’s hunger centres, it helps individuals consume fewer calories, leading to significant weight loss. Clinical trials for Wegovy have yielded remarkable results. Participants in these studies experienced an average weight loss of 15% of their initial body weight over 68 weeks, surpassing the outcomes achieved with many other weight-loss interventions.
Combining Forces: Metformin and Wegovy
The convergence of Metformin and Wegovy represents a unique approach to weight management. Some healthcare providers are exploring the potential synergies between these two medications, leveraging Metformin’s glucose-regulating effects alongside Wegovy’s appetite control properties. By combining these medications, individuals may benefit from improved blood sugar control, reduced appetite, and enhanced weight-loss results. However, this approach requires careful monitoring and personalised treatment plans to ensure safety and effectiveness.
3. Tirzepatide: A New Player
A new player from Eli Lilly, the pharmaceutical company, is Tirzepatide, due to gain approval in 2024. It has the potential to normalise blood sugar levels in an impressive 81 to 97 per cent of patients—a significant leap compared to its competitors.
While Tirzepatide’s primary role centres around diabetes management, it also emerges as a potent weight-loss ally—a beacon of hope for type 2 diabetes patients grappling with obesity-related complications such as high blood pressure. This medication is recommended for individuals with a body mass index (BMI) exceeding 35, or those unable to use insulin injections.
Eli Lilly has extended its ambitions beyond diabetes treatment, actively seeking approval for Tirzepatide for weight-loss treatments within the NHS. Encouragingly, clinical trials hint at Tirzepatide’s potential to achieve weight loss of up to 26 per cent—an impressive stride beyond the approximately 15 per cent achieved by Novo Nordisk’s Wegovy. Tirzepatide is to be marketed under the name Mounjaro in the UK.
When the drugs stop, as they will….
While Metformin, Wegovy, along with Tirzepatide are offering exciting possibilities, it’s crucial to note, however, the indications are that they will cease to work the day you stop taking them. Many people are expected to experience ‘creep’ and ‘regain’ in the months following. So, maybe it will be a lifelong journey, and what if Government funding for the drug is reversed?
The solution being recommended is to combine taking the drugs in-conjunction with the completing of a proven programme such as Oxford Therapeutics ‘My Weigh Less’. The programme incorporates elements that can yield improved outcomes. CBT, for instance, empowers individuals to identify and modify negative thought patterns related to food, body image, and self-esteem. This is crucial for tackling emotional eating, promoting healthier relationships with food, and addressing the psychological underpinnings of weight gain. Oxford Therapeutics psychological programme has been shown to be the perfect partner for Wegovy.
In conclusion, while the drugs mentioned above offer a potential avenue for weight loss, it’s essential to acknowledge their limitations. Combining them with psychological support and embracing sustainable lifestyle changes is key to long-term success. Patients must be reminded that their weight-loss journey is unique, and completing a psychological reset programme will help to deliver the desired weight loss expected, and permanently.
As research continues and medical science advances, the future of weight management is looking increasingly promising. However, individuals seeking to embark on weight-loss journeys should approach these medications with caution and in partnership with their doctor, emphasising the importance of holistic care for sustained success.
Our Top FAQs: Wegovy, Metformin and Tirzepatide
Answer: Metformin primarily works by reducing the liver’s production of glucose and improving insulin sensitivity. These effects help stabilise blood sugar levels, which in turn has implications for weight management. While the weight loss achieved with Metformin may be modest, typically around 5%, it offers hope for those struggling to shed excess pounds. Some individuals taking Metformin have reported positive outcomes, especially when combined with lifestyle modifications.
Answer: Wegovy is an FDA-approved injectable medication designed specifically for obesity management. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by suppressing appetite and increasing feelings of fullness. It targets the brain’s hunger centres, helping individuals consume fewer calories, which leads to significant weight loss. Clinical trials for Wegovy have shown remarkable results, with participants experiencing an average weight loss of 15% of their initial body weight over 68 weeks, surpassing many other weight-loss interventions.
Answer: The convergence of Metformin and Wegovy represents a unique approach to weight management. Some healthcare providers are exploring the potential synergies between these two medications, leveraging Metformin’s glucose-regulating effects alongside Wegovy’s appetite control properties. By combining these medications, individuals may benefit from improved blood sugar control, reduced appetite, and enhanced weight-loss results. However, this approach requires careful monitoring and personalised treatment plans to ensure safety and effectiveness.
Answer: Tirzepatide, a medication from Eli Lilly, is primarily designed for diabetes management, but it also shows promise as a weight-loss ally. It is recommended for individuals with a body mass index (BMI) exceeding 35 or those unable to use insulin injections. Tirzepatide has the potential to normalise blood sugar levels in a significant percentage of patients, and clinical trials suggest it can achieve weight loss of up to 26%. This makes it a noteworthy option for those dealing with obesity-related complications.
Answer: It’s important to note that these medications may cease to be effective when you stop taking them, leading to ‘creep’ and weight ‘regain.’ This suggests that weight loss achieved with these drugs might require ongoing use. Government funding for these drugs may also change in the future, making long-term use uncertain.
Answer: The ‘My Weigh Less’ programme from Oxford Therapeutics incorporates elements like Cognitive Behavioural Therapy (CBT) to help individuals identify and modify negative thought patterns related to food, body image, and self-esteem. This is crucial for tackling emotional eating, promoting healthier relationships with food, and addressing the psychological underpinnings of weight gain. Combining this programme with medications like Wegovy can enhance outcomes and provide a more holistic approach to weight management.
Answer: While the mentioned medications offer potential avenues for weight loss, it’s essential to acknowledge their limitations. Combining them with psychological support and embracing sustainable lifestyle changes is key to long-term success. Patients must understand that their weight-loss journey is unique, and completing a psychological reset programme can help deliver the desired weight loss and maintain it.
Answer: As research in medical science advances, the future of weight management looks promising. However, individuals seeking to embark on weight-loss journeys should approach these medications with caution and in partnership with their doctor, emphasising the importance of holistic care for sustained success. It’s crucial to consult with healthcare professionals and create a personalized plan that combines medication, psychological support, and lifestyle changes to achieve lasting results.
Are you tired of trying an endless list of diets that just don’t work? Frustrated with the constant cycle of losing and regaining weight? Are you looking for a medically endorsed solution, one based on thousands of hours of clinical experience? Maybe something that doesn’t involve following a restrictive diet, doing lots of exercise, or having invasive surgery…? So, go ahead, relax, and take a few minutes to daydream… What would it be like to be slim and healthy, to be at your target weight? Can you imagine if you never had to go on a diet again or be afraid of food? What if you were able to enjoy every social event with the fantastic feeling of extra energy and improved self-esteem? Welcome to My Weigh Less Master Class – The Gold Standard in Permanent Weight Loss.
Read on to find out about our award-winning solution! But first, allow us to introduce ourselves. We are Martin and Marion Shirran, and we have worked in the field of weight loss for almost 20 years. We are both clinical therapists and the developers of the globally acclaimed Gastric Mind Band Permanent Weight-Loss Treatment. Articles about our treatment and successful clients have appeared in the global media, including The Times, The Telegraph and the Express. Additionally, magazines such as Vogue, Marie Claire, Good Housekeeping, Hello, Woman, Reader’s Digest and Psychologies have featured our work, as have TV shows around the world.
MWL effortlessly delivers the dieter into the eye of the dieting storm. On a psychological level, it delivers a profound and excitingly new approach to the introduction of change in a person’s life. The treatment allows participants to seamlessly overcome their negative issues around food and eating in general, resulting in them being able to make the connection between weight loss and wellness.
Wegovy, Metformin and Tirzepatide
During the twelve one-hour sessions that make up the programme, dieters learn about aspects of obesity and weight loss that they may have never associated as being connected. The programme has been built around a combination of empirically proven interventions. These include TactileCBT, Cognitive Behaviour Therapy and Neuro-Linguistic Programming, as well as Clinical Hypnotherapy. The treatment is designed to connect your mind with your body, delivering a simple, clean connection between Weight Loss and Wellness.
Over a thousand people travelled from around the world to experience our weight-loss treatment. Our clients include celebrities, members of the public and medical professionals, including doctors, dentists, nurses, anaesthetists and consultant surgeons. Some clients simply want to shed their excess weight to look better. However, others tell us that health is the main reason. Many of our past clients have successfully reversed medical conditions such as insulin resistance, diabetes, high blood pressure, and fatty liver disease, whereas others have managed to avoid having knee or hip replacement surgery. You may like to read more details on our Medical Endorsements page.
Our weight-loss approach has been the subject of continued research and development over the last thirteen years. Sharon, above, lost 75 pounds. Our youngest client was just fourteen, and the oldest was eighty-six. Some clients wished to lose just a few pounds to fit into their wedding dress. But others, like Sarah below, went on to lose over 140 pounds. As a result, she was featured globally on TV and in the press. Follow this link to sign up for our course now, and you can start your weight-loss journey today.
Our psychology-focused weight loss programme provides a ‘Psychological Reset’ for those wishing to lose weight. The programme incorporates an updated version of Cognitive Behaviour Therapy, TCBT, which is the subject of our bestselling book, published globally by Hay House. Professor Windy Dryden of Goldsmiths University in London endorsed the book, and Professor Philip Zimbardo of Stanford University in the USA wrote the foreword. We also incorporate the latest developments around Neuroplasticity and Neuro-Linguistic Programming along with many other disciplines. One component of our psychology-focused weight loss programme provides a ‘Psychological Reset’. At this statement, ‘Psychological Reset,’ we have observed many people raising their eyebrows; see below.
Let me give you a couple of examples: the programme will allow you to make a number of simple cognitive changes in your thought processes…small changes that deliver ‘massive results’. For example, think for a moment how different your relationship with food and weight loss would be if we re-programmed your subconscious mind to effortlessly replace the word “want” with the word “need”?
The result: imagine you are out having dinner with friends, and after ordering a burger. Instead of hearing the waiter asking: “Do you ‘want’ fries with that?” without thinking, you hear and automatically process the question as: “Do you ‘need’ fries with that?” Things would be very different, right? You see, at a cognitive level, we process those words differently. Later, maybe the waiter says, do you ‘want’ another glass of wine? You, of course, hear and cognitively process the word stream as do you ‘need’ another glass of wine. You can watch an animated video explaining ‘Want and Need’ and how it works at the bottom of this page.
Another ‘fix’ in the programme relates to just why people eat. So, during the programme, you will be asked when was the last time you ate in response to actual, physical hunger. Most people say: “Thinking about it, I haven’t been physically hungry for years”. And so we ask them: “Do you ever eat when you are bored, stressed, tired, lonely, depressed, sad, to reward yourself, when watching TV, or maybe just to please someone else?” Then, we do another reset, and so it goes on…
We have over 100 blog post articles on the site, covering many different topics. The blog page section is updated regularly; take a look by following this Blog Page Link.
Martin and Marion Shirran
We have spent many months completely reformatting our unique, phenomenally successful approach to weight loss. As a result, the course is now instantly available to download to your phone, tablet, or computer. This also means that you can complete the entire course without having to leave the comfort and security of your own home. Welcome to the ‘My Weigh Less Master Class’!
Read on the pages of this website how the award-winning ‘My Weigh Less’ downloadable treatment is successfully delivering what is surely ‘utopia’ to dieters: a medically endorsed, proven weight-loss approach that provides permanent results! The programme is also based on over 15,000 1:1 clinical treatment hours. My Weigh Less can help you reach your weight-loss goals.
– Permanent Weight Loss –
– No Diet or Exercise Required –
– Medically Endorsed –
– 15,000 1:1 Clinical Hours Experience –
– Fully Downloadable –
– Featured in Global Media –
– Award-Winning Programme –
Marion Shirran, as a director of Oxford Therapeutics Limited, is proud to be a registered Stakeholder in NICE – National Institute for Health and Care Excellence. Marion is also involved in the government’s All-Party Parliamentary Group on Obesity.
We were proud to be awarded the ‘Most Innovative Obesity Psychological Therapy’ in the UK Mental Health Awards 2022.
We also appeared on the This Morning TV show with Holly Willoughby and Phillip Schofield.
In 2010, we travelled to New York to be interviewed on the Good Morning America TV Show.
We are also co-authors of two bestselling books about non-surgical weight loss, published by Hay House.
You can read a full breakdown of all the components included in the treatment package on the Course Details page. There is also an explanation of the treatment on the Does This Work? page. We look forward to working with you. Additionally, you can read reviews from medical and other professionals on the Medical Endorsement page.
Watch the Short Animated ‘Want and Need Video’ Below…
Downloadable Weight-Loss Treatment
My Weigh Less®/myweighless.com and all associated intellectual property rights are the property of Oxford Therapeutics Limited, a company registered in London.
You can read additional information about us and our weight-loss treatment on the Gastric Mind Band website.
Although the weight-loss results and success stories shown on the site are typical, individual results will vary, and are not guaranteed. Weight-loss success depends on each individual’s level of motivation, commitment, food intake and metabolism. Read our full disclaimer in the Terms & Conditions.